Evidence map›Paper›PMID 29699520›Full record

ArticleBMC public health2018

A methodological framework for the evaluation of syndromic surveillance systems: a case study of England.

Felipe J Colón-González, Iain R Lake, Roger A Morbey, Alex J Elliot, Richard Pebody, Gillian E Smith

Abstract read
In one paragraph

Article in BMC public health, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. [Transformation of Epidemiology in the Age of Artificial Intelligence].Revista medica del Instituto Mexicano del Seguro Social · 2026
    Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Syndromic Surveillance Systems for Mass Gatherings: A Scoping Review.International journal of environmental research and public health · 2022
    Article
  11. Article
  12. Article
  13. Evaluating multi-purpose syndromic surveillance systems - a complex problem.Online journal of public health informatics · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Felipe J Colón-GonzálezSchool of Environmental Sciences, University of East Anglia, Norwich, NR4 7TJ, UK. F.Colon@uea.ac.uk.ORCID 0000-0002-9671-3405
Iain R LakeSchool of Environmental Sciences, University of East Anglia, Norwich, NR4 7TJ, UK.
Roger A MorbeyReal-time Syndromic Surveillance Team, National Infection Service, Public Health England, Birmingham, B3 2PW, UK.
Alex J ElliotReal-time Syndromic Surveillance Team, National Infection Service, Public Health England, Birmingham, B3 2PW, UK.
Richard PebodyRespiratory Diseases Department, National Infection Service, Public Health England, London, NW9 5EQ, UK.
Gillian E SmithReal-time Syndromic Surveillance Team, National Infection Service, Public Health England, Birmingham, B3 2PW, UK.

Funding

National Institute for Health Research HPRU-2012-10141
6 · The paper itself

Abstract

backgroundSyndromic surveillance complements traditional public health surveillance by collecting and analysing health indicators in near real time. The rationale of syndromic surveillance is that it may detect health threats faster than traditional surveillance systems permitting more timely, and hence potentially more effective public health action. The effectiveness of syndromic surveillance largely relies on the methods used to detect aberrations. Very few studies have evaluated the performance of syndromic surveillance systems and consequently little is known about the types of events that such systems can and cannot detect.

methodsWe introduce a framework for the evaluation of syndromic surveillance systems that can be used in any setting based upon the use of simulated scenarios. For a range of scenarios this allows the time and probability of detection to be determined and uncertainty is fully incorporated. In addition, we demonstrate how such a framework can model the benefits of increases in the number of centres reporting syndromic data and also determine the minimum size of outbreaks that can or cannot be detected. Here, we demonstrate its utility using simulations of national influenza outbreaks and localised outbreaks of cryptosporidiosis.

resultsInfluenza outbreaks are consistently detected with larger outbreaks being detected in a more timely manner. Small cryptosporidiosis outbreaks (<1000 symptomatic individuals) are unlikely to be detected. We also demonstrate the advantages of having multiple syndromic data streams (e.g. emergency attendance data, telephone helpline data, general practice consultation data) as different streams are able to detect different outbreak types with different efficacy (e.g. emergency attendance data are useful for the detection of pandemic influenza but not for outbreaks of cryptosporidiosis). We also highlight that for any one disease, the utility of data streams may vary geographically, and that the detection ability of syndromic surveillance varies seasonally (e.g. an influenza outbreak starting in July is detected sooner than one starting later in the year). We argue that our framework constitutes a useful tool for public health emergency preparedness in multiple settings.

conclusionsThe proposed framework allows the exhaustive evaluation of any syndromic surveillance system and constitutes a useful tool for emergency preparedness and response.

Indexed as

Sentinel SurveillanceCryptosporidiosisDisease OutbreaksEnglandHumansInfluenza, HumanPandemicsPublic Health SurveillanceCryptosporidiosisInfluenzaScenariosSimulationSyndromic surveillance

Identifiers

PMID29699520
PMCPMC5921418

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.